Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Three-dimensional Measurements of Diabetic Foot Ulcers

11 marzo 2019 aggiornato da: Line Bisgaard Jørgensen, Odense University Hospital

Three-dimensional Measurements for Monitoring Wound Healing of Diabetic Foot Ulcers

Diabetic foot ulcers constitute an increasing health problem in Denmark concurrent with an ageing population and an increase in diabetes prevalence. Diabetic foot ulcers belong to the most serious and costly complications. Several studies have found that the size and depth of the ulcer is one of the major etiologic factors for delayed healing. Wound measurement is important in the monitoring of the wound healing process. For the last decade different 3D (three-dimensional) techniques for measuring wounds have been proposed in order to measure wound volume, but none of the technologies have been widely used. A 3D Wound Assessment Monitor (WAM) camera has been developed, which is able to measure wound size in 3D and to assess wound characteristics.

The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.

Panoramica dello studio

Descrizione dettagliata

Method

Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.

At baseline the following patient data will be collected:

  • Demographic data: gender, age
  • Smoking habits
  • Time period between onset of wound to first visit in the multidisciplinary clinic
  • Body Mass Index
  • Comorbidity using Charlson Comorbidity Index score
  • Type of diabetes, duration of diabetes
  • Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy

The following examinations will be performed at baseline:

  • Blood pressure measurement
  • Peripheral blood pressure
  • Examination for neuropathy using monofilament
  • Blood samples from patients with a diabetic foot ulcer

The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:

  • Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
  • Size of wound in 2D area using the digital imaging method with the software ImageJ
  • Location of the ulcer
  • Classification of ulcer: granulation, necrosis, epithelialisation
  • Secretory potential
  • Foot deformity
  • Bone affection - if osteitis is suspected an x-ray is taken
  • Signs of infection

The different types of ulcer treatment is registered for every ulcer:

  • Type of bandage
  • Antibiotics (local, systemic)
  • Revision (method, frequency),
  • Surgery

Effect variables

  • Wound 2D area, 3D area, perimeter and volume
  • Variation in 2D and 3D area measurements during the study period
  • Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks

Endpoints

  • Wound healing
  • Amputations
  • Chronic wound (non-healing after 1 year)
  • Death

Significance

This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

150

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Odense, Danimarca, 5000
        • University Centre of Wound Healing, Odense University Hospital (OUH)

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Newly admitted patients with diabetic foot ulcer to University Centre for Wound Healing, Odense University Hospital.

Descrizione

Inclusion Criteria:

  • Newly admitted patients with diabetic foot ulcers
  • 18 years or older

Exclusion Criteria:

  • Superficial wound (less than 5x5 mm with no substantial loss of subcutaneous tissue)
  • Non-compliance (dementia, mental disorders)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Altri nomi:
  • 3D-WAM camera

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Wound healing change quantified using the 3D-WAM camera
Lasso di tempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 3D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Wound healing change quantified using digital imaging method
Lasso di tempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 2D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The variability in 2D area and 3D area measurements
Lasso di tempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The variability in 2D area (digital imaging method) and 3D area wound measurements (3D-WAM camera) at week 0, 2, 4, 8, 12, 24, 36 and 52 are compared
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Diabetes type is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
Type 1 and 2
Baseline until healing, amputation or chronic wound (52 weeks)
Diabetes duration is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
In years
Baseline until healing, amputation or chronic wound (52 weeks)
BMI (kg/m2) is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
kg/m2
Baseline until healing, amputation or chronic wound (52 weeks)
Charlson index score is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
In groups
Baseline until healing, amputation or chronic wound (52 weeks)
HbA1c is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
mmol/mol
Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is defined by ankle pressure below 70 mmHg and/or toe pressure below 45 mmHg
Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is measured by Semmes Weinstein monofilament examination
Baseline until healing, amputation or chronic wound (52 weeks)
Wound duration is compared to outcome of the wound
Lasso di tempo: Baseline until healing, amputation or chronic wound (52 weeks)
In weeks
Baseline until healing, amputation or chronic wound (52 weeks)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Quality of life (Questionaires) using 36-Item Short Form Survey (SF-36) is compared to outcome of the wound
Lasso di tempo: Baseline, 24 and 52 weeks
The higher the score the less disability
Baseline, 24 and 52 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Knud Yderstræde, MD, PhD, Department of Endocrinology, Odense University Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 agosto 2015

Completamento primario (Effettivo)

1 dicembre 2018

Completamento dello studio (Effettivo)

1 dicembre 2018

Date di iscrizione allo studio

Primo inviato

15 aprile 2015

Primo inviato che soddisfa i criteri di controllo qualità

19 aprile 2015

Primo Inserito (Stima)

22 aprile 2015

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 marzo 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 marzo 2019

Ultimo verificato

1 marzo 2019

Maggiori informazioni

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi